Table of Content

1 Recombinant Human Insulin Market Overview
1.1 Product Overview and Scope of Recombinant Human Insulin
1.2 Recombinant Human Insulin Segment by Recombinant DNA Technology Using Fermentation in Bacteria Way
1.2.1 Global Recombinant Human Insulin Sales Growth Rate Comparison by Recombinant DNA Technology Using Fermentation in Bacteria Way (2021-2027)


1.3 Recombinant Human Insulin Segment by Application
1.3.1 Recombinant Human Insulin Sales Comparison by Application: (2021-2027)
1.3.2 Type 1 Diabetes Mellitus
1.3.3 Type 2 Diabetes Mellitus
1.4 Global Recombinant Human Insulin Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Insulin Revenue 2016-2027
1.4.2 Global Recombinant Human Insulin Sales 2016-2027
1.4.3 Recombinant Human Insulin Market Size by Region: 2016 Versus 2021 Versus 2027

2 Recombinant Human Insulin Market Competition by Manufacturers
2.1 Global Recombinant Human Insulin Sales Market Share by Manufacturers (2016-2021)
2.2 Global Recombinant Human Insulin Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Recombinant Human Insulin Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Recombinant Human Insulin Manufacturing Sites, Area Served, Product Type
2.5 Recombinant Human Insulin Market Competitive Situation and Trends
2.5.1 Recombinant Human Insulin Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Recombinant Human Insulin Players Market Share by Revenue
2.5.3 Global Recombinant Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Recombinant Human Insulin Retrospective Market Scenario by Region
3.1 Global Recombinant Human Insulin Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Recombinant Human Insulin Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Recombinant Human Insulin Market Facts & Figures by Country
3.3.1 North America Recombinant Human Insulin Sales by Country
3.3.2 North America Recombinant Human Insulin Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Recombinant Human Insulin Market Facts & Figures by Country
3.4.1 Europe Recombinant Human Insulin Sales by Country
3.4.2 Europe Recombinant Human Insulin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Recombinant Human Insulin Market Facts & Figures by Region
3.5.1 Asia Pacific Recombinant Human Insulin Sales by Region
3.5.2 Asia Pacific Recombinant Human Insulin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Recombinant Human Insulin Market Facts & Figures by Country
3.6.1 Latin America Recombinant Human Insulin Sales by Country
3.6.2 Latin America Recombinant Human Insulin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Recombinant Human Insulin Market Facts & Figures by Country
3.7.1 Middle East and Africa Recombinant Human Insulin Sales by Country
3.7.2 Middle East and Africa Recombinant Human Insulin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Recombinant Human Insulin Historic Market Analysis by Type
4.1 Global Recombinant Human Insulin Sales Market Share by Type (2016-2021)
4.2 Global Recombinant Human Insulin Revenue Market Share by Type (2016-2021)
4.3 Global Recombinant Human Insulin Price by Type (2016-2021)

5 Global Recombinant Human Insulin Historic Market Analysis by Application
5.1 Global Recombinant Human Insulin Sales Market Share by Application (2016-2021)
5.2 Global Recombinant Human Insulin Revenue Market Share by Application (2016-2021)
5.3 Global Recombinant Human Insulin Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Akron Biotech
6.1.1 Akron Biotech Corporation Information
6.1.2 Akron Biotech Description and Business Overview
6.1.3 Akron Biotech Recombinant Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Akron Biotech Product Portfolio
6.1.5 Akron Biotech Recent Developments/Updates
6.2 Wockhardt
6.2.1 Wockhardt Corporation Information
6.2.2 Wockhardt Description and Business Overview
6.2.3 Wockhardt Recombinant Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Wockhardt Product Portfolio
6.2.5 Wockhardt Recent Developments/Updates
6.3 Dance Biopharm
6.3.1 Dance Biopharm Corporation Information
6.3.2 Dance Biopharm Description and Business Overview
6.3.3 Dance Biopharm Recombinant Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Dance Biopharm Product Portfolio
6.3.5 Dance Biopharm Recent Developments/Updates
6.4 Novo Nordisk
6.4.1 Novo Nordisk Corporation Information
6.4.2 Novo Nordisk Description and Business Overview
6.4.3 Novo Nordisk Recombinant Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Novo Nordisk Product Portfolio
6.4.5 Novo Nordisk Recent Developments/Updates
6.5 Gan & Lee
6.5.1 Gan & Lee Corporation Information
6.5.2 Gan & Lee Description and Business Overview
6.5.3 Gan & Lee Recombinant Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Gan & Lee Product Portfolio
6.5.5 Gan & Lee Recent Developments/Updates
6.6 United Laboratories
6.6.1 United Laboratories Corporation Information
6.6.2 United Laboratories Description and Business Overview
6.6.3 United Laboratories Recombinant Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.6.4 United Laboratories Product Portfolio
6.6.5 United Laboratories Recent Developments/Updates
6.7 Dongbro Pharmaceuticri
6.6.1 Dongbro Pharmaceuticri Corporation Information
6.6.2 Dongbro Pharmaceuticri Description and Business Overview
6.6.3 Dongbro Pharmaceuticri Recombinant Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Dongbro Pharmaceuticri Product Portfolio
6.7.5 Dongbro Pharmaceuticri Recent Developments/Updates

7 Recombinant Human Insulin Manufacturing Cost Analysis
7.1 Recombinant Human Insulin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Recombinant Human Insulin
7.4 Recombinant Human Insulin Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Recombinant Human Insulin Distributors List
8.3 Recombinant Human Insulin Customers

9 Recombinant Human Insulin Market Dynamics
9.1 Recombinant Human Insulin Industry Trends
9.2 Recombinant Human Insulin Growth Drivers
9.3 Recombinant Human Insulin Market Challenges
9.4 Recombinant Human Insulin Market Restraints

10 Global Market Forecast
10.1 Recombinant Human Insulin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Recombinant Human Insulin by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Recombinant Human Insulin by Type (2022-2027)
10.2 Recombinant Human Insulin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Recombinant Human Insulin by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Recombinant Human Insulin by Application (2022-2027)
10.3 Recombinant Human Insulin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Recombinant Human Insulin by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Recombinant Human Insulin by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Recombinant Human Insulin Sales (g) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Recombinant Human Insulin Sales (g) Comparison by Application (2021-2027)
Table 3. Global Recombinant Human Insulin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Recombinant Human Insulin Covered in This Study
Table 5. Global Recombinant Human Insulin Sales (g) of Key Manufacturers (2016-2021)
Table 6. Global Recombinant Human Insulin Sales Share by Manufacturers (2016-2021)
Table 7. Global Recombinant Human Insulin Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Recombinant Human Insulin Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Recombinant Human Insulin Average Price (USD/mg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Recombinant Human Insulin Manufacturing Sites and Area Served
Table 11. Manufacturers Recombinant Human Insulin Product Type
Table 12. Global Recombinant Human Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Recombinant Human Insulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Insulin as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Recombinant Human Insulin Sales by Region (2016-2021) & (g)
Table 16. Global Recombinant Human Insulin Sales Market Share by Region (2016-2021)
Table 17. Global Recombinant Human Insulin Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Recombinant Human Insulin Sales by Country (2016-2021) & (g)
Table 19. North America Recombinant Human Insulin Sales Market Share by Country (2016-2021)
Table 20. North America Recombinant Human Insulin Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Recombinant Human Insulin Revenue Market Share by Country (2016-2021)
Table 22. Europe Recombinant Human Insulin Sales by Country (2016-2021) & (g)
Table 23. Europe Recombinant Human Insulin Sales Market Share by Country (2016-2021)
Table 24. Europe Recombinant Human Insulin Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Recombinant Human Insulin Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Recombinant Human Insulin Sales by Region (2016-2021) & (g)
Table 27. Asia Pacific Recombinant Human Insulin Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Recombinant Human Insulin Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Recombinant Human Insulin Revenue Market Share by Region (2016-2021)
Table 30. Latin America Recombinant Human Insulin Sales by Country (2016-2021) & (g)
Table 31. Latin America Recombinant Human Insulin Sales Market Share by Country (2016-2021)
Table 32. Latin America Recombinant Human Insulin Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Recombinant Human Insulin Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Recombinant Human Insulin Sales by Country (2016-2021) & (g)
Table 35. Middle East and Africa Recombinant Human Insulin Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Recombinant Human Insulin Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Recombinant Human Insulin Revenue Market Share by Country (2016-2021)
Table 38. Global Recombinant Human Insulin Sales (g) by Type (2016-2021)
Table 39. Global Recombinant Human Insulin Sales Market Share by Type (2016-2021)
Table 40. Global Recombinant Human Insulin Revenue (Million US$) by Type (2016-2021)
Table 41. Global Recombinant Human Insulin Revenue Share by Type (2016-2021)
Table 42. Global Recombinant Human Insulin Price (USD/mg) by Type (2016-2021)
Table 43. Global Recombinant Human Insulin Sales (g) by Application (2016-2021)
Table 44. Global Recombinant Human Insulin Sales Market Share by Application (2016-2021)
Table 45. Global Recombinant Human Insulin Revenue (Million US$) by Application (2016-2021)
Table 46. Global Recombinant Human Insulin Revenue Share by Application (2016-2021)
Table 47. Global Recombinant Human Insulin Price (USD/mg) by Application (2016-2021)
Table 48. Akron Biotech Corporation Information
Table 49. Akron Biotech Description and Business Overview
Table 50. Akron Biotech Recombinant Human Insulin Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 51. Akron Biotech Recombinant Human Insulin Product
Table 52. Akron Biotech Recent Developments/Updates
Table 53. Wockhardt Corporation Information
Table 54. Wockhardt Description and Business Overview
Table 55. Wockhardt Recombinant Human Insulin Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 56. Wockhardt Recombinant Human Insulin Product
Table 57. Wockhardt Recent Developments/Updates
Table 58. Dance Biopharm Corporation Information
Table 59. Dance Biopharm Description and Business Overview
Table 60. Dance Biopharm Recombinant Human Insulin Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 61. Dance Biopharm Recombinant Human Insulin Product
Table 62. Dance Biopharm Recent Developments/Updates
Table 63. Novo Nordisk Corporation Information
Table 64. Novo Nordisk Description and Business Overview
Table 65. Novo Nordisk Recombinant Human Insulin Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 66. Novo Nordisk Recombinant Human Insulin Product
Table 67. Novo Nordisk Recent Developments/Updates
Table 68. Gan & Lee Corporation Information
Table 69. Gan & Lee Description and Business Overview
Table 70. Gan & Lee Recombinant Human Insulin Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 71. Gan & Lee Recombinant Human Insulin Product
Table 72. Gan & Lee Recent Developments/Updates
Table 73. United Laboratories Corporation Information
Table 74. United Laboratories Description and Business Overview
Table 75. United Laboratories Recombinant Human Insulin Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 76. United Laboratories Recombinant Human Insulin Product
Table 77. United Laboratories Recent Developments/Updates
Table 78. Dongbro Pharmaceuticri Corporation Information
Table 79. Dongbro Pharmaceuticri Description and Business Overview
Table 80. Dongbro Pharmaceuticri Recombinant Human Insulin Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 81. Dongbro Pharmaceuticri Recombinant Human Insulin Product
Table 82. Dongbro Pharmaceuticri Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Recombinant Human Insulin Distributors List
Table 86. Recombinant Human Insulin Customers List
Table 87. Recombinant Human Insulin Market Trends
Table 88. Recombinant Human Insulin Growth Drivers
Table 89. Recombinant Human Insulin Market Restraints
Table 90. Global Recombinant Human Insulin Sales Forecast by Type (2022-2027) & (g)
Table 91. Global Recombinant Human Insulin Sales Market Share Forecast by Type (2022-2027)
Table 92. Global Recombinant Human Insulin Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 93. Global Recombinant Human Insulin Revenue Market Share Forecast by Type (2022-2027)
Table 94. Global Recombinant Human Insulin Sales Forecast by Application (2022-2027) & (g)
Table 95. Global Recombinant Human Insulin Sales Market Share Forecast by Application (2022-2027)
Table 96. Global Recombinant Human Insulin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 97. Global Recombinant Human Insulin Revenue Market Share Forecast by Application (2022-2027)
Table 98. Global Recombinant Human Insulin Sales Forecast by Region (2022-2027) & (g)
Table 99. Global Recombinant Human Insulin Sales Market Share Forecast by Region (2022-2027)
Table 100. Global Recombinant Human Insulin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 101. Global Recombinant Human Insulin Revenue Market Share Forecast by Region (2022-2027)
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Recombinant Human Insulin
Figure 2. Global Recombinant Human Insulin Market Share by Type in 2020 & 2027
Figure 3. Product Picture
Figure 4. Product Picture
Figure 5. Global Recombinant Human Insulin Market Share by Application in 2020 & 2027
Figure 6. Type 1 Diabetes Mellitus
Figure 7. Type 2 Diabetes Mellitus
Figure 8. Global Recombinant Human Insulin Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Recombinant Human Insulin Market Size 2016-2027 (US$ Million)
Figure 10. Global Recombinant Human Insulin Sales 2016-2027 (g)
Figure 11. Global Recombinant Human Insulin Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Recombinant Human Insulin Sales Share by Manufacturers in 2020
Figure 13. Global Recombinant Human Insulin Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Recombinant Human Insulin Players: Market Share by Revenue in 2020
Figure 15. Recombinant Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Recombinant Human Insulin Sales Market Share by Region (2016-2021)
Figure 17. Global Recombinant Human Insulin Sales Market Share by Region in 2020
Figure 18. Global Recombinant Human Insulin Revenue Market Share by Region (2016-2021)
Figure 19. Global Recombinant Human Insulin Revenue Market Share by Region in 2020
Figure 20. U.S. Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. U.A.E Recombinant Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Recombinant Human Insulin by Type (2016-2021)
Figure 45. Sales Market Share of Recombinant Human Insulin by Application (2016-2021)
Figure 46. Sales Market Share of Recombinant Human Insulin by Application in 2020
Figure 47. Revenue Share of Recombinant Human Insulin by Application (2016-2021)
Figure 48. Revenue Share of Recombinant Human Insulin by Application in 2020
Figure 49. Manufacturing Cost Structure of Recombinant Human Insulin
Figure 50. Manufacturing Process Analysis of Recombinant Human Insulin
Figure 51. Recombinant Human Insulin Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed